Safety Alert of Risk of severe itching after discontinuation of long-term use of Cetirizine and Levocetirizine Abdul Mateen Safety Alerts February 9, 2026February 9, 2026 66-Safety-Alert-of-Risk-of-severe-itching-after-discontinuation-of-long-term-use-of-CetirizineDownload
Safety Alert of Risk of Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION) with Semaglutide Abdul Mateen Safety Alerts February 6, 2026February 6, 2026 65-Safety-Alert-of-Risk-of-Non-Arteritic-Anterior-Ischemic-Optic-Neuropathy-NAION-with-SemaglutideDownload
Safety Alert of Risk of Circulatory Shock with the Sulfamethoxazole and trimethoprim drug combination Abdul Mateen Safety Alerts February 6, 2026February 6, 2026 64-Safety-Alert-of-Risk-of-Circulatory-Shock-with-the-Sulfamethoxazole-and-trimethoprim-drug-combinationDownload
Safety Alert of Potential Risk of Suicidal Thoughts with Finasteride and Dutasteride-containing medicines Abdul Mateen Safety Alerts February 3, 2026February 3, 2026 63-Safety-Alert-of-Potential-Risk-of-Suicidal-Thoughts-with-Finasteride-and-Dutasteride-containing-meDownload
Safety Alert of Risk of Intrahepatic Cholestasis of Pregnancy with Thiopurines Abdul Mateen Safety Alerts February 3, 2026February 3, 2026 62-Safety-Alert-of-Risk-of-Intrahepatic-Cholestasis-of-Pregnancy-with-ThiopurinesDownload
Safety Alert of Risk of Idiopathic Intracranial Hypertension with Mesalazine Abdul Mateen Safety Alerts January 30, 2026January 30, 2026 61-Safety-Alert-of-Risk-of-Idiopathic-Intracranial-Hypertension-with-Mesalazine-1Download
Safety Alert of Risk of Sacroiliitis with Isotretinoin Abdul Mateen Safety Alerts January 30, 2026January 30, 2026 60-Safety-Alert-of-Risk-of-Sacroiliitis-with-IsotretinoinDownload
Suspension of marketing authorisations of 17-Hydroxyprogesterone caproate (17- OHPC) due to its ineffectiveness in authorised uses Abdul Qadir Safety Alerts July 9, 2025July 18, 2025SafetyAlert 58-Suspension-of-marketing-authorisations-of-17-OHPC-due-to-its-un-effectivenessDownload
Risk of Meningioma with Medroxyprogesterone Acetate. Abdul Qadir Safety Alerts July 9, 2025July 9, 2025 59-Risk-of-meningioma-with-Medroxyprogesterone-AcetateDownload
Potential Risk of Tumour Lysis Syndrome with Sorafenib Abdul Qadir Safety Alerts April 25, 2025July 18, 2025 57-Potential-Risk-of-Tumour-Lysis-Syndrome-with-SorafenibDownload
